Menu
GeneBe

6-33080863-A-G

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002121.6(HLA-DPB1):ā€‹c.292A>Gā€‹(p.Lys98Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.231 in 1,607,872 control chromosomes in the GnomAD database, including 45,336 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K98R) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.24 ( 4752 hom., cov: 31)
Exomes š‘“: 0.23 ( 40584 hom. )

Consequence

HLA-DPB1
NM_002121.6 missense

Scores

1
16

Clinical Significance

risk factor no assertion criteria provided O:1

Conservation

PhyloP100: -5.80
Variant links:
Genes affected
HLA-DPB1 (HGNC:4940): (major histocompatibility complex, class II, DP beta 1) HLA-DPB belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DPA) and a beta chain (DPB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DP molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to 4 different molecules. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046232343).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.36 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HLA-DPB1NM_002121.6 linkuse as main transcriptc.292A>G p.Lys98Glu missense_variant 2/6 ENST00000418931.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HLA-DPB1ENST00000418931.7 linkuse as main transcriptc.292A>G p.Lys98Glu missense_variant 2/6 NM_002121.6 P1

Frequencies

GnomAD3 genomes
AF:
0.243
AC:
36832
AN:
151860
Hom.:
4758
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.264
Gnomad AMI
AF:
0.208
Gnomad AMR
AF:
0.231
Gnomad ASJ
AF:
0.271
Gnomad EAS
AF:
0.374
Gnomad SAS
AF:
0.359
Gnomad FIN
AF:
0.164
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.224
Gnomad OTH
AF:
0.273
GnomAD3 exomes
AF:
0.246
AC:
61054
AN:
247988
Hom.:
8236
AF XY:
0.254
AC XY:
34068
AN XY:
134314
show subpopulations
Gnomad AFR exome
AF:
0.266
Gnomad AMR exome
AF:
0.175
Gnomad ASJ exome
AF:
0.267
Gnomad EAS exome
AF:
0.378
Gnomad SAS exome
AF:
0.349
Gnomad FIN exome
AF:
0.165
Gnomad NFE exome
AF:
0.228
Gnomad OTH exome
AF:
0.264
GnomAD4 exome
AF:
0.230
AC:
334467
AN:
1455894
Hom.:
40584
Cov.:
55
AF XY:
0.234
AC XY:
169307
AN XY:
724122
show subpopulations
Gnomad4 AFR exome
AF:
0.259
Gnomad4 AMR exome
AF:
0.188
Gnomad4 ASJ exome
AF:
0.267
Gnomad4 EAS exome
AF:
0.396
Gnomad4 SAS exome
AF:
0.348
Gnomad4 FIN exome
AF:
0.166
Gnomad4 NFE exome
AF:
0.216
Gnomad4 OTH exome
AF:
0.242
GnomAD4 genome
AF:
0.242
AC:
36831
AN:
151978
Hom.:
4752
Cov.:
31
AF XY:
0.245
AC XY:
18189
AN XY:
74292
show subpopulations
Gnomad4 AFR
AF:
0.264
Gnomad4 AMR
AF:
0.231
Gnomad4 ASJ
AF:
0.271
Gnomad4 EAS
AF:
0.374
Gnomad4 SAS
AF:
0.358
Gnomad4 FIN
AF:
0.164
Gnomad4 NFE
AF:
0.224
Gnomad4 OTH
AF:
0.271
Alfa
AF:
0.230
Hom.:
1333
Bravo
AF:
0.248
TwinsUK
AF:
0.190
AC:
703
ALSPAC
AF:
0.188
AC:
726
ESP6500AA
AF:
0.249
AC:
751
ESP6500EA
AF:
0.224
AC:
1214
ExAC
AF:
0.251
AC:
30306
EpiCase
AF:
0.239
EpiControl
AF:
0.254

ClinVar

Significance: risk factor
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Beryllium disease, chronic, susceptibility to Other:1
risk factor, no assertion criteria providedliterature onlyOMIMNov 07, 2000- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.0090
DANN
Benign
0.42
DEOGEN2
Benign
0.026
T;T
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.014
N
MetaRNN
Benign
0.0046
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.76
N;.
MutationTaster
Benign
1.0
P;P;P
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-1.4
N;N
REVEL
Uncertain
0.36
Sift
Benign
0.29
T;T
Sift4G
Benign
0.50
T;T
Polyphen
0.0
B;.
Vest4
0.052
MPC
1.0
ClinPred
0.010
T
GERP RS
-8.0
Varity_R
0.13
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1042140; hg19: chr6-33048640; COSMIC: COSV69602323; COSMIC: COSV69602323; API